Pharma & Biotech

The French vaccine developer Valneva finds itself at a pivotal moment, with its future prospects increasingly tied to the success...

Walgreens shareholders are navigating a complex landscape as the pharmacy giant completes its transition to private ownership while confronting substantial...

Johnson & Johnson is demonstrating remarkable momentum on dual fronts. The healthcare conglomerate's shares are approaching a fresh annual peak,...

The biotechnology sector is watching closely as Incyte Corporation announces a significant leadership transition within its financial operations. Thomas Tray,...

Shares of Arvinas are experiencing a significant rally following the release of encouraging clinical trial results for its Parkinson's disease...

Harmony Biosciences Holdings faces a severe market downturn following the disappointing outcome of a pivotal clinical study. Investor confidence has...

Eli Lilly finds itself navigating conflicting signals as substantial insider selling coincides with ambitious worldwide growth initiatives. This divergence presents...

The landscape of cancer diagnostics is undergoing a profound transformation, with Exact Sciences emerging as a pivotal innovator. The company's...

Cellectar Biosciences has achieved a critical regulatory milestone that could pave the way for European commercialization of its cancer therapeutic...

Bruker Corporation witnessed a substantial uptick in its share price following the announcement of significant new contract awards. Investor sentiment...